Nebraska LB 210: Provide for fees and assessments for participation and use of the prescription drug monitoring program and the designated health information exchange

Status: Indefinitely postponed (as of 2026-04-17)

State: Nebraska · Session: 109 · Bill: LB 210

Sponsors: Riepe

View Nebraska LB 210 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.